Cell-Based Immunization Combined with Single-Round Cell Panning Enables Discovery of PSMA-Targeting Nanobodies from Phage Display Libraries
Year: 2026
Type: article
Abstract: There is a strong need for nanobodies that target novel cancer-associated antigens to advance radioligand imaging and antibody-based therapeutics. In this study, we investigated whether non-targeted llama immunization using tumor cells, combined with non-targeted phage-display panning of human cell lines, could yield nanobodies specific to Prostate-Specific Membrane Antigen (PSMA). Nanobody selection using both classical three-round PSMA negative-positive panning and single-round panning of cell lines (positive or negative) for PSMA showed clear enrichment for PSMA binders in both strategies. Using shRNA knockdown, flow cytometry, cell-ELISA, immunohistochemistry and structural modeling and docking, we confirmed the PSMA-targeting of selected nanobodies. Two distinct epitopes were predicted to be bound by nanobodies PSMANb9 and A7 (JVZ-007), and this was corroborated by epitope competition assays. These findings support the feasibility of non-targeted immunization and panning strategies for isolating antigen-targeting cancer nanobodies.
Source: Biomolecules
DOI: 10.3390/biom16020307
Authors: Tong Yang, Joke Veldhoven-Zweistra, Maarten Ligtenberg, Sigrun Erkens, Mirella Vredenbregt-van den Berg, Rick Jansen, Patrick Chames, Eric M.J. Bindels, Khadijeh Ahmadi, Chris H. Bangma, Anton M. F. Kalsbeek, Janne Leivo, Nicolaas Lumen, Harmen J. G. van de Werken, Wytske M. van Weerden, Soudabeh Kavousipour, Raheleh Tooyserkani, Guido Jenster
Institutions: Erasmus MC Cancer Institute, Centre National de la Recherche Scientifique, Inserm, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Erasmus MC, Bushehr University of Medical Sciences, University of Turku, Ghent University Hospital, Ghent University, Hormozgan University of Medical Sciences
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,258
Awards: G145492932, G6447439057
OpenAlex ID: W7128964054
